PDB Short entry for 3ROV HEADER HORMONE 26-APR-11 3ROV TITLE INSULIN'S BIOSYNTHESIS AND ACTIVITY HAVE OPPOSING STRUCTURAL TITLE 2 REQUIREMENTS: A NEW FACTOR IN NEONATAL DIABETES MELLITUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A, C, E, G, I, K; COMPND 4 SYNONYM: INSULIN A CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INSULIN; COMPND 8 CHAIN: B, D, F, H, J, L; COMPND 9 SYNONYM: INSULIN B CHAIN; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HUMANS; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606 KEYWDS ZINC-BINDING SITE, LONG-ACTING INSULIN ANALOG, RECEPTOR BINDING KEYWDS 2 PROTEIN ENGINEERING, GLOBAL HEALTH, INSULIN FIBRILLATION, KEYWDS 3 STABILIZING, HORMONE EXPDTA X-RAY DIFFRACTION AUTHOR M.A.WEISS,Z.L.WAN,E.J.DODSON,M.LIU,B.XU,Q.X.HUA,M.TURKENBURG, AUTHOR 2 J.WHITTINGHAM,S.H.NAKAGAWA,K.HUANG,S.Q.HU,W.H.JIA,S.H.WANG,J.BRANGE, AUTHOR 3 J.WHITTAKER,P.ARVAN,P.G.KATSOYANNIS,G.G.DODSON REVDAT 3 13-SEP-23 3ROV 1 REMARK SEQADV LINK REVDAT 2 08-NOV-17 3ROV 1 REMARK REVDAT 1 02-MAY-12 3ROV 0 JRNL AUTH M.A.WEISS,Z.L.WAN,E.J.DODSON,M.LIU,B.XU,Q.X.HUA, JRNL AUTH 2 M.TURKENBURG,J.WHITTINGHAM,S.H.NAKAGAWA,K.HUANG,S.Q.HU, JRNL AUTH 3 W.H.JIA,S.H.WANG,J.BRANGE,J.WHITTAKER,P.ARVAN, JRNL AUTH 4 P.G.KATSOYANNIS,G.G.DODSON JRNL TITL INSULIN'S BIOSYNTHESIS AND ACTIVITY HAVE OPPOSING STRUCTURAL JRNL TITL 2 REQUIREMENTS: A NEW FACTOR IN NEONATAL DIABETES MELLITUS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Z.L.WAN,K.HUANG,B.XU,S.Q.HU,S.WANG,Y.C.CHU,P.G.KATSOYANNIS, REMARK 1 AUTH 2 M.A.WEISS REMARK 1 TITL DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN: CRYSTAL REMARK 1 TITL 2 STRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A-CHAIN VARIANT REMARK 1 TITL 3 INSULIN WAKAYAMA. REMARK 1 REF BIOCHEMISTRY V. 44 5000 2005 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH Z.L.WAN,B.XU,Y.C.CHU,P.G.KATSOYANNIS,M.A.WEISS REMARK 1 TITL CRYSTAL STRUCTURE OF ALLO-ILE(A2)-INSULIN, AN INACTIVE REMARK 1 TITL 2 CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR REMARK 1 TITL 3 BINDING REMARK 1 REF BIOCHEMISTRY V. 42 12770 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH Z.L.WAN,B.XU,Y.C.CHU,B.LI,S.H.NAKAGAWA,Y.QU,S.Q.HU, REMARK 1 AUTH 2 P.G.KATSOYANNIS,M.A.WEISS REMARK 1 TITL ENHANCING THE ACTIVITY OF INSULIN AT THE RECEPTOR INTERFACE: REMARK 1 TITL 2 CRYSTAL STRUCTURE AND PHOTO-CROSS-LINKING OF A8 ANALOGUES. REMARK 1 REF BIOCHEMISTRY V. 43 16119 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 4 REMARK 1 AUTH E.N.BAKER,T.L.BLUNDELL,J.F.CUTFIELD,S.M.CUTFIELD,E.J.DODSON, REMARK 1 AUTH 2 G.G.DODSON,D.HODGKIN,N.W.ISAACS,C.D.REYNOLDS REMARK 1 TITL THE STRUCTURE OF 2ZN PIG INSULIN CRYSTAL AT 1.5 A RESOLUTION REMARK 1 REF PHILOS.TRANS.R.SOC.LONDON, V. 319 369 1988 REMARK 1 REF 2 SER.B REMARK 1 REFN ISSN 0080-4622 REMARK 1 REFERENCE 5 REMARK 1 AUTH G.BENTLEY,E.DODSON,G.DODSON,D.HODGKIN,D.MERCOLA REMARK 1 TITL STRUCTURE OF INSULIN IN 4-ZINC INSULIN REMARK 1 REF NATURE V. 261 166 1976 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 6 REMARK 1 AUTH U.DEREWENDA,Z.DEREWENDA,E.DODSON,G.DODSON,C.REYNOLD,G.SMITH, REMARK 1 AUTH 2 C.SPARKS,D.SWENSON REMARK 1 TITL PHENOL STABILIZES MORE HELIX IN A NEW SYMMETRICAL ZINC REMARK 1 TITL 2 INSULIN HEXAMER REMARK 1 REF NATURE V. 338 594 1989 REMARK 1 REFN ISSN 0028-0836 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 10280 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.307 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1032 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE : 0.4180 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 132 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.034 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2442 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.28000 REMARK 3 B22 (A**2) : -0.38000 REMARK 3 B33 (A**2) : 0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.58000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.24 REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 3.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3ROV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-APR-11. REMARK 100 THE DEPOSITION ID IS D_1000065196. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-OCT-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : DOUBLE CRYSTAL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10607 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 44.360 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.23200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 32.80 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1ZNJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M SODIUM CITRATE, 1% PHENOL, REMARK 280 0.04% ZINC ACETATE, PH 8.3, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.88600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DODECAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H, I, J, REMARK 350 AND CHAINS: K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: I, J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN G 21 O ARG H 22 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO D 29 58.59 -65.85 REMARK 500 DAL F 20 -107.12 48.35 REMARK 500 DAL F 23 178.81 52.46 REMARK 500 PRO H 29 69.79 -51.87 REMARK 500 CYS I 20 -166.35 -75.10 REMARK 500 DAL L 20 -86.57 33.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 31 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 10 NE2 REMARK 620 2 HIS F 10 NE2 110.2 REMARK 620 3 HIS J 10 NE2 106.3 103.0 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN D 31 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 10 NE2 REMARK 620 2 HIS H 10 NE2 108.3 REMARK 620 3 HIS L 10 NE2 102.6 90.7 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH A 22 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 31 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 32 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH C 22 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN D 31 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH E 22 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH G 22 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL H 31 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH I 22 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH K 22 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZNJ RELATED DB: PDB REMARK 900 RR STATE INSULIN CRYSTAL STRUCTURE DBREF 3ROV A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 3ROV B 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 3ROV C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 3ROV D 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 3ROV E 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 3ROV F 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 3ROV G 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 3ROV H 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 3ROV I 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 3ROV J 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 3ROV K 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 3ROV L 1 30 UNP P01308 INS_HUMAN 25 54 SEQADV 3ROV DAL B 20 UNP P01308 GLY 44 ENGINEERED MUTATION SEQADV 3ROV DAL B 23 UNP P01308 GLY 47 ENGINEERED MUTATION SEQADV 3ROV LYS B 28 UNP P01308 PRO 52 ENGINEERED MUTATION SEQADV 3ROV PRO B 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQADV 3ROV DAL D 20 UNP P01308 GLY 44 ENGINEERED MUTATION SEQADV 3ROV DAL D 23 UNP P01308 GLY 47 ENGINEERED MUTATION SEQADV 3ROV LYS D 28 UNP P01308 PRO 52 ENGINEERED MUTATION SEQADV 3ROV PRO D 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQADV 3ROV DAL F 20 UNP P01308 GLY 44 ENGINEERED MUTATION SEQADV 3ROV DAL F 23 UNP P01308 GLY 47 ENGINEERED MUTATION SEQADV 3ROV LYS F 28 UNP P01308 PRO 52 ENGINEERED MUTATION SEQADV 3ROV PRO F 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQADV 3ROV DAL H 20 UNP P01308 GLY 44 ENGINEERED MUTATION SEQADV 3ROV DAL H 23 UNP P01308 GLY 47 ENGINEERED MUTATION SEQADV 3ROV LYS H 28 UNP P01308 PRO 52 ENGINEERED MUTATION SEQADV 3ROV PRO H 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQADV 3ROV DAL J 20 UNP P01308 GLY 44 ENGINEERED MUTATION SEQADV 3ROV DAL J 23 UNP P01308 GLY 47 ENGINEERED MUTATION SEQADV 3ROV LYS J 28 UNP P01308 PRO 52 ENGINEERED MUTATION SEQADV 3ROV PRO J 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQADV 3ROV DAL L 20 UNP P01308 GLY 44 ENGINEERED MUTATION SEQADV 3ROV DAL L 23 UNP P01308 GLY 47 ENGINEERED MUTATION SEQADV 3ROV LYS L 28 UNP P01308 PRO 52 ENGINEERED MUTATION SEQADV 3ROV PRO L 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS DAL GLU ARG DAL PHE PHE TYR SEQRES 3 B 30 THR LYS PRO THR SEQRES 1 C 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 30 ALA LEU TYR LEU VAL CYS DAL GLU ARG DAL PHE PHE TYR SEQRES 3 D 30 THR LYS PRO THR SEQRES 1 E 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 E 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 F 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 F 30 ALA LEU TYR LEU VAL CYS DAL GLU ARG DAL PHE PHE TYR SEQRES 3 F 30 THR LYS PRO THR SEQRES 1 G 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 G 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 H 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 H 30 ALA LEU TYR LEU VAL CYS DAL GLU ARG DAL PHE PHE TYR SEQRES 3 H 30 THR LYS PRO THR SEQRES 1 I 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 I 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 J 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 J 30 ALA LEU TYR LEU VAL CYS DAL GLU ARG DAL PHE PHE TYR SEQRES 3 J 30 THR LYS PRO THR SEQRES 1 K 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 K 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 L 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 L 30 ALA LEU TYR LEU VAL CYS DAL GLU ARG DAL PHE PHE TYR SEQRES 3 L 30 THR LYS PRO THR HET DAL B 20 5 HET DAL B 23 5 HET DAL D 20 5 HET DAL D 23 5 HET DAL F 20 5 HET DAL F 23 5 HET DAL H 20 5 HET DAL H 23 5 HET DAL J 20 5 HET DAL J 23 5 HET DAL L 20 5 HET DAL L 23 5 HET IPH A 22 7 HET ZN B 31 1 HET CL B 32 1 HET IPH C 22 7 HET ZN D 31 1 HET IPH E 22 7 HET IPH G 22 7 HET CL H 31 1 HET IPH I 22 7 HET IPH K 22 7 HETNAM DAL D-ALANINE HETNAM IPH PHENOL HETNAM ZN ZINC ION HETNAM CL CHLORIDE ION FORMUL 2 DAL 12(C3 H7 N O2) FORMUL 13 IPH 6(C6 H6 O) FORMUL 14 ZN 2(ZN 2+) FORMUL 15 CL 2(CL 1-) FORMUL 23 HOH *186(H2 O) HELIX 1 1 GLY A 1 CYS A 7 1 7 HELIX 2 2 SER A 12 GLU A 17 1 6 HELIX 3 3 PHE B 1 DAL B 20 1 20 HELIX 4 4 GLY C 1 CYS C 7 1 7 HELIX 5 5 SER C 12 GLU C 17 1 6 HELIX 6 6 ASN C 18 CYS C 20 5 3 HELIX 7 7 PHE D 1 DAL D 20 1 20 HELIX 8 8 GLU D 21 DAL D 23 5 3 HELIX 9 9 GLY E 1 CYS E 7 1 7 HELIX 10 10 SER E 12 GLU E 17 1 6 HELIX 11 11 ASN E 18 CYS E 20 5 3 HELIX 12 12 PHE F 1 DAL F 20 1 20 HELIX 13 13 GLY G 1 CYS G 7 1 7 HELIX 14 14 SER G 12 ASN G 18 1 7 HELIX 15 15 VAL H 2 DAL H 20 1 19 HELIX 16 16 GLU H 21 DAL H 23 5 3 HELIX 17 17 GLY I 1 CYS I 7 1 7 HELIX 18 18 SER I 12 ASN I 18 1 7 HELIX 19 19 VAL J 2 DAL J 20 1 19 HELIX 20 20 GLU J 21 DAL J 23 5 3 HELIX 21 21 GLY K 1 SER K 9 1 9 HELIX 22 22 SER K 12 CYS K 20 5 9 HELIX 23 23 VAL L 2 DAL L 20 1 19 SHEET 1 A 2 PHE B 24 TYR B 26 0 SHEET 2 A 2 PHE D 24 TYR D 26 -1 O PHE D 24 N TYR B 26 SHEET 1 B 2 PHE F 25 TYR F 26 0 SHEET 2 B 2 PHE H 24 PHE H 25 -1 O PHE H 24 N TYR F 26 SHEET 1 C 2 PHE J 24 TYR J 26 0 SHEET 2 C 2 PHE L 24 TYR L 26 -1 O TYR L 26 N PHE J 24 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.03 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.04 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.03 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.04 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.04 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.04 SSBOND 7 CYS E 6 CYS E 11 1555 1555 2.03 SSBOND 8 CYS E 7 CYS F 7 1555 1555 2.04 SSBOND 9 CYS E 20 CYS F 19 1555 1555 2.02 SSBOND 10 CYS G 6 CYS G 11 1555 1555 2.04 SSBOND 11 CYS G 7 CYS H 7 1555 1555 2.03 SSBOND 12 CYS G 20 CYS H 19 1555 1555 2.03 SSBOND 13 CYS I 6 CYS I 11 1555 1555 2.03 SSBOND 14 CYS I 7 CYS J 7 1555 1555 2.03 SSBOND 15 CYS I 20 CYS J 19 1555 1555 2.03 SSBOND 16 CYS K 6 CYS K 11 1555 1555 2.03 SSBOND 17 CYS K 7 CYS L 7 1555 1555 2.03 SSBOND 18 CYS K 20 CYS L 19 1555 1555 2.04 LINK C CYS B 19 N DAL B 20 1555 1555 1.32 LINK C DAL B 20 N GLU B 21 1555 1555 1.33 LINK C ARG B 22 N DAL B 23 1555 1555 1.32 LINK C DAL B 23 N PHE B 24 1555 1555 1.33 LINK C CYS D 19 N DAL D 20 1555 1555 1.34 LINK C DAL D 20 N GLU D 21 1555 1555 1.33 LINK C ARG D 22 N DAL D 23 1555 1555 1.33 LINK C DAL D 23 N PHE D 24 1555 1555 1.33 LINK C CYS F 19 N DAL F 20 1555 1555 1.34 LINK C DAL F 20 N GLU F 21 1555 1555 1.34 LINK C ARG F 22 N DAL F 23 1555 1555 1.33 LINK C DAL F 23 N PHE F 24 1555 1555 1.32 LINK C CYS H 19 N DAL H 20 1555 1555 1.33 LINK C DAL H 20 N GLU H 21 1555 1555 1.33 LINK C ARG H 22 N DAL H 23 1555 1555 1.33 LINK C DAL H 23 N PHE H 24 1555 1555 1.32 LINK C CYS J 19 N DAL J 20 1555 1555 1.33 LINK C DAL J 20 N GLU J 21 1555 1555 1.32 LINK C ARG J 22 N DAL J 23 1555 1555 1.32 LINK C DAL J 23 N PHE J 24 1555 1555 1.32 LINK C CYS L 19 N DAL L 20 1555 1555 1.32 LINK C DAL L 20 N GLU L 21 1555 1555 1.34 LINK C ARG L 22 N DAL L 23 1555 1555 1.31 LINK C DAL L 23 N PHE L 24 1555 1555 1.35 LINK NE2 HIS B 10 ZN ZN B 31 1555 1555 2.06 LINK ZN ZN B 31 NE2 HIS F 10 1555 1555 2.08 LINK ZN ZN B 31 NE2 HIS J 10 1555 1555 2.07 LINK NE2 HIS D 10 ZN ZN D 31 1555 1555 2.04 LINK ZN ZN D 31 NE2 HIS H 10 1555 1555 2.11 LINK ZN ZN D 31 NE2 HIS L 10 1555 1555 2.09 SITE 1 AC1 4 CYS A 6 ILE A 10 CYS A 11 HIS F 5 SITE 1 AC2 4 HIS B 10 CL B 32 HIS F 10 HIS J 10 SITE 1 AC3 2 ZN B 31 HIS J 10 SITE 1 AC4 5 CYS C 6 ILE C 10 CYS C 11 LEU D 11 SITE 2 AC4 5 HIS L 5 SITE 1 AC5 4 HIS D 10 HIS H 10 CL H 31 HIS L 10 SITE 1 AC6 5 CYS E 6 ILE E 10 CYS E 11 HIS F 10 SITE 2 AC6 5 LEU J 6 SITE 1 AC7 5 CYS G 6 CYS G 11 LEU G 16 HIS H 10 SITE 2 AC7 5 ALA H 14 SITE 1 AC8 2 ZN D 31 HIS H 10 SITE 1 AC9 5 HIS B 5 CYS I 6 ILE I 10 CYS I 11 SITE 2 AC9 5 LEU J 11 SITE 1 BC1 5 HIS H 5 CYS K 6 ILE K 10 CYS K 11 SITE 2 BC1 5 LEU L 11 CRYST1 45.662 61.772 46.038 90.00 105.50 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021900 0.000000 0.006073 0.00000 SCALE2 0.000000 0.016189 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022541 0.00000